News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Upsher-Smith Laboratories Completes Acquisition of Proximagen Group plc.


8/14/2012 9:44:05 AM

MAPLE GROVE, Minn.--(BUSINESS WIRE)--Upsher-Smith Laboratories, Inc. today announced that on Tuesday, August 14, 2012 it completed its acquisition of UK-based Proximagen Group plc (AIM: PRX), a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system (CNS) and inflammation. The acquisition was approved by Proximagen’s shareholders.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES